(AXS) AXIS Capital Holdings - Overview
Exchange: NYSE •
Country: Bermuda •
Currency: USD •
Type: Common Stock •
ISIN: BMG0692U1099
Stock: Insurance, Reinsurance, Liability, Property, Marine
Total Rating 48
Risk 80
Buy Signal 0.12
| Risk 5d forecast | |
|---|---|
| Volatility | 23.0% |
| Relative Tail Risk | -0.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.42 |
| Alpha | 0.76 |
| Character TTM | |
|---|---|
| Beta | 0.435 |
| Beta Downside | 0.853 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.73% |
| CAGR/Max DD | 1.70 |
EPS (Earnings per Share)
Revenue
Description: AXS AXIS Capital Holdings March 05, 2026
AXIS Capital Holdings Ltd. (AXS) is a specialty insurer and reinsurer operating globally, with headquarters in Bermuda. The company functions through two primary segments: Insurance and Reinsurance.
The Insurance segment provides a wide array of specialized coverages. These include professional liability (e.g., D&O, E&O), property insurance for various commercial and residential risks, and marine and aviation insurance. This segment also offers personal accident, travel, specialty health, pet, cyber, and credit/political risk insurance. Specialty insurance focuses on niche markets or unique risks that standard policies may not cover.
The Reinsurance segment offers coverage to other insurance companies across numerous categories. These include agriculture, marine and aviation, catastrophe, accident and health, credit and surety, motor, professional, travel, life, engineering, property, and liability reinsurance products. Reinsurance helps primary insurers manage their risk exposure and capital.
To gain deeper insights into AXSs financial performance and competitive landscape, ValueRay offers detailed analytics.
Headlines to watch out for
- Catastrophe losses impact reinsurance segment profitability
- Specialty insurance pricing drives revenue growth
- Investment portfolio returns influence earnings
- Regulatory changes affect underwriting capacity
- Economic downturns reduce insurance demand
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 1.01b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA -5.77 > 1.0 |
| NWC/Revenue: 163.2% < 20% (prev 296.0%; Δ -132.8% < -1%) |
| CFO/TA -0.00 > 3% & CFO -40.9m > Net Income 1.01b |
| Net Debt (282.1m) to EBITDA (1.39b): 0.20 < 3 |
| Current Ratio: 3.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (76.8m) vs 12m ago -9.80% < -2% |
| Gross Margin: 36.07% > 18% (prev 0.30%; Δ 3.58k% > 0.5%) |
| Asset Turnover: 19.85% > 50% (prev 18.51%; Δ 1.34% > 0%) |
| Interest Coverage Ratio: 19.33 > 6 (EBITDA TTM 1.39b / Interest Expense TTM 66.7m) |
Altman Z'' 3.56
| A: 0.33 (Total Current Assets 14.19b - Total Current Liabilities 3.69b) / Total Assets 32.32b |
| B: 0.25 (Retained Earnings 8.18b / Total Assets 32.32b) |
| C: 0.04 (EBIT TTM 1.29b / Avg Total Assets 32.42b) |
| D: 0.32 (Book Value of Equity 8.21b / Total Liabilities 25.97b) |
| Altman-Z'' Score: 3.56 = A |
Beneish M -2.76
| DSRI: 1.13 (Receivables 12.87b/10.67b, Revenue 6.44b/6.02b) |
| GMI: 0.82 (GM 36.07% / 29.74%) |
| AQI: 1.41 (AQ_t 0.56 / AQ_t-1 0.40) |
| SGI: 1.07 (Revenue 6.44b / 6.02b) |
| TATA: 0.03 (NI 1.01b - CFO -40.9m) / TA 32.32b) |
| Beneish M-Score: -2.76 (Cap -4..+1) = A |
What is the price of AXS shares?
As of March 16, 2026, the stock is trading at USD 100.90 with a total of 436,894 shares traded.
Over the past week, the price has changed by -0.53%, over one month by -3.31%, over three months by -4.84% and over the past year by +7.41%.
Over the past week, the price has changed by -0.53%, over one month by -3.31%, over three months by -4.84% and over the past year by +7.41%.
Is AXS a buy, sell or hold?
AXIS Capital Holdings has received a consensus analysts rating of 4.11.
Therefore, it is recommended to buy AXS.
- StrongBuy: 4
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AXS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 123.6 | 22.5% |
| Analysts Target Price | 123.6 | 22.5% |
AXS Fundamental Data Overview March 16, 2026
P/E Trailing = 8.17
P/E Forward = 7.4184
P/S = 1.1843
P/B = 1.2853
P/EG = 1.1787
Revenue TTM = 6.44b USD
EBIT TTM = 1.29b USD
EBITDA TTM = 1.39b USD
Long Term Debt = 1.32b USD (from longTermDebt, last quarter)
Short Term Debt = 109.0m USD (from shortTermDebt, two quarters ago)
Debt = 1.60b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 282.1m USD (from netDebt column, last quarter)
Enterprise Value = 8.06b USD (7.77b + Debt 1.60b - CCE 1.32b)
Interest Coverage Ratio = 19.33 (Ebit TTM 1.29b / Interest Expense TTM 66.7m)
EV/FCF = -196.8x (Enterprise Value 8.06b / FCF TTM -40.9m)
FCF Yield = -0.51% (FCF TTM -40.9m / Enterprise Value 8.06b)
FCF Margin = -0.64% (FCF TTM -40.9m / Revenue TTM 6.44b)
Net Margin = 15.68% (Net Income TTM 1.01b / Revenue TTM 6.44b)
Gross Margin = 36.07% ((Revenue TTM 6.44b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Gross Margin QoQ = 50.45% (prev 33.44%)
Tobins Q-Ratio = 0.25 (Enterprise Value 8.06b / Total Assets 32.32b)
Interest Expense / Debt = 1.05% (Interest Expense 16.8m / Debt 1.60b)
Taxrate = 13.70% (46.0m / 335.6m)
NOPAT = 1.11b (EBIT 1.29b * (1 - 13.70%))
Current Ratio = 3.85 (Total Current Assets 14.19b / Total Current Liabilities 3.69b)
Debt / Equity = 0.25 (Debt 1.60b / totalStockholderEquity, last quarter 6.36b)
Debt / EBITDA = 0.20 (Net Debt 282.1m / EBITDA 1.39b)
Debt / FCF = -6.89 (negative FCF - burning cash) (Net Debt 282.1m / FCF TTM -40.9m)
Total Stockholder Equity = 6.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.11% (Net Income 1.01b / Total Assets 32.32b)
RoE = 16.27% (Net Income TTM 1.01b / Total Stockholder Equity 6.20b)
RoCE = 17.14% (EBIT 1.29b / Capital Employed (Equity 6.20b + L.T.Debt 1.32b))
RoIC = 15.81% (NOPAT 1.11b / Invested Capital 7.03b)
WACC = 6.39% (E(7.77b)/V(9.38b) * Re(7.52%) + D(1.60b)/V(9.38b) * Rd(1.05%) * (1-Tc(0.14)))
Discount Rate = 7.52% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -5.08%
[DCF] Fair Price = unknown (Cash Flow -40.9m)
EPS Correlation: 45.73 | EPS CAGR: 12.49% | SUE: 0.52 | # QB: 0
Revenue Correlation: 92.45 | Revenue CAGR: 7.86% | SUE: 2.12 | # QB: 2
EPS next Quarter (2026-06-30): EPS=3.47 | Chg7d=+0.010 | Chg30d=+0.009 | Revisions Net=+1 | Analysts=11
EPS current Year (2026-12-31): EPS=13.36 | Chg7d=+0.037 | Chg30d=+0.039 | Revisions Net=+2 | Growth EPS=+3.4% | Growth Revenue=+5.4%
EPS next Year (2027-12-31): EPS=14.56 | Chg7d=+0.042 | Chg30d=+0.037 | Revisions Net=+2 | Growth EPS=+9.0% | Growth Revenue=+7.1%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -4.3% (Discount Rate 7.9% - Earnings Yield 12.2%)
[Growth] Growth Spread = +11.7% (Analyst 7.4% - Implied -4.3%)
P/E Forward = 7.4184
P/S = 1.1843
P/B = 1.2853
P/EG = 1.1787
Revenue TTM = 6.44b USD
EBIT TTM = 1.29b USD
EBITDA TTM = 1.39b USD
Long Term Debt = 1.32b USD (from longTermDebt, last quarter)
Short Term Debt = 109.0m USD (from shortTermDebt, two quarters ago)
Debt = 1.60b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 282.1m USD (from netDebt column, last quarter)
Enterprise Value = 8.06b USD (7.77b + Debt 1.60b - CCE 1.32b)
Interest Coverage Ratio = 19.33 (Ebit TTM 1.29b / Interest Expense TTM 66.7m)
EV/FCF = -196.8x (Enterprise Value 8.06b / FCF TTM -40.9m)
FCF Yield = -0.51% (FCF TTM -40.9m / Enterprise Value 8.06b)
FCF Margin = -0.64% (FCF TTM -40.9m / Revenue TTM 6.44b)
Net Margin = 15.68% (Net Income TTM 1.01b / Revenue TTM 6.44b)
Gross Margin = 36.07% ((Revenue TTM 6.44b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Gross Margin QoQ = 50.45% (prev 33.44%)
Tobins Q-Ratio = 0.25 (Enterprise Value 8.06b / Total Assets 32.32b)
Interest Expense / Debt = 1.05% (Interest Expense 16.8m / Debt 1.60b)
Taxrate = 13.70% (46.0m / 335.6m)
NOPAT = 1.11b (EBIT 1.29b * (1 - 13.70%))
Current Ratio = 3.85 (Total Current Assets 14.19b / Total Current Liabilities 3.69b)
Debt / Equity = 0.25 (Debt 1.60b / totalStockholderEquity, last quarter 6.36b)
Debt / EBITDA = 0.20 (Net Debt 282.1m / EBITDA 1.39b)
Debt / FCF = -6.89 (negative FCF - burning cash) (Net Debt 282.1m / FCF TTM -40.9m)
Total Stockholder Equity = 6.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.11% (Net Income 1.01b / Total Assets 32.32b)
RoE = 16.27% (Net Income TTM 1.01b / Total Stockholder Equity 6.20b)
RoCE = 17.14% (EBIT 1.29b / Capital Employed (Equity 6.20b + L.T.Debt 1.32b))
RoIC = 15.81% (NOPAT 1.11b / Invested Capital 7.03b)
WACC = 6.39% (E(7.77b)/V(9.38b) * Re(7.52%) + D(1.60b)/V(9.38b) * Rd(1.05%) * (1-Tc(0.14)))
Discount Rate = 7.52% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -5.08%
[DCF] Fair Price = unknown (Cash Flow -40.9m)
EPS Correlation: 45.73 | EPS CAGR: 12.49% | SUE: 0.52 | # QB: 0
Revenue Correlation: 92.45 | Revenue CAGR: 7.86% | SUE: 2.12 | # QB: 2
EPS next Quarter (2026-06-30): EPS=3.47 | Chg7d=+0.010 | Chg30d=+0.009 | Revisions Net=+1 | Analysts=11
EPS current Year (2026-12-31): EPS=13.36 | Chg7d=+0.037 | Chg30d=+0.039 | Revisions Net=+2 | Growth EPS=+3.4% | Growth Revenue=+5.4%
EPS next Year (2027-12-31): EPS=14.56 | Chg7d=+0.042 | Chg30d=+0.037 | Revisions Net=+2 | Growth EPS=+9.0% | Growth Revenue=+7.1%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -4.3% (Discount Rate 7.9% - Earnings Yield 12.2%)
[Growth] Growth Spread = +11.7% (Analyst 7.4% - Implied -4.3%)